WASHINGTON, Sept. 20 (UPI) -- A Canadian company's 15-year effort to develop and sell genetically engineered salmon to consumers is getting a public airing in Washington.
The U.S. Food and Drug Administration is holding public meetings Monday and Tuesday to address science-based issues, and receive public comment about AquaBounty Technologies' proposal to sell the fish, the FDA said.